Skip to main content
Top
Published in: Lasers in Medical Science 8/2019

01-10-2019 | Benign Prostatic Hypertrophy | Original Article

Thulium vapoenucleation of the prostate (ThuVEP) for prostates larger than 85 ml: long-term durability of the procedure

Authors: Benedikt Becker, Ann Kathrin Orywal, Andreas J. Gross, Christopher Netsch

Published in: Lasers in Medical Science | Issue 8/2019

Login to get access

Abstract

The purpose of this prospective study of 90 consecutive patients is to assess the long-term durability of ThuVEP in patients with benign prostatic hyperplasia (BPH) and prostate volumes ≥ 85 ml. Ninety patients with prostates ≥ 85 ml underwent ThuVEP between 2008 and 2010 at our institution. Patient demographics and short-term and long-term follow-up were evaluated. Maximum urinary flow rate (Qmax), post-void residual urine (PVR), international prostate symptom score (IPSS), quality of life (QoL), complications, and PSA were assessed at follow-up. Median age at surgery was 71 (66–75.25) years. Thirty-seven (41.1%) of the patients were in urinary retention at the time of surgery. Prostate volume was 100 (88–122) ml. Median follow-up was 36.5 (16–60) months. At 12-month follow-up, IPSS, QoL, Qmax, and PVR had improved significantly compared with preoperative assessment and continued to do so during follow-up (p < 0.001). At 4-year postoperative, median Qmax (19.1 vs. 7.75 ml/s), PVR (31.9 vs. 150 ml), IPSS (4.5 vs. 24), and QoL (1 vs. 5) differed significantly from baseline (p ≤ 0.027). PSA decreased from 7.4 (4.14–14) to 0.70 (0.36–1.64) μg/l (p < 0.001) at 48-month follow-up, corresponding to a PSA reduction of 86.48% (79.85–95.25%). Urinary tract infections occurred in 2 (2.2%) patients. Urethral stricture and bladder neck contracture developed in 1 (1.1%) patient each. One patient (1.1%) had recurrent adenoma of the prostate and was treated with thulium vaporesection of the prostate. ThuVEP is a durable modern alternative to open prostatectomy for patients with substantially enlarged prostates due to BPH. The incidence of complications with ThuVEP during long-term follow-up was low.
Literature
5.
go back to reference Fraundorfer MR, Gilling PJ (1998) Holmium:YAG laser enucleation of the prostate combined with mechanical morcellation: preliminary results. Eur Urol 33:69–72CrossRefPubMed Fraundorfer MR, Gilling PJ (1998) Holmium:YAG laser enucleation of the prostate combined with mechanical morcellation: preliminary results. Eur Urol 33:69–72CrossRefPubMed
20.
go back to reference Pearce SM, Pariser JJ, Malik RD et al (2016) Outcomes following thulium vapoenucleation of large prostates. Int Braz J Urol Off J Braz Soc Urol 42:757–765CrossRef Pearce SM, Pariser JJ, Malik RD et al (2016) Outcomes following thulium vapoenucleation of large prostates. Int Braz J Urol Off J Braz Soc Urol 42:757–765CrossRef
26.
go back to reference Becker B, Herrmann TRW, Gross AJ, Netsch C (2018) Thulium vapoenucleation of the prostate versus holmium laser enucleation of the prostate for the treatment of large volume prostates: preliminary 6-month safety and efficacy results of a prospective randomized trial. World J Urol. https://doi.org/10.1007/s00345-018-2321-8 Becker B, Herrmann TRW, Gross AJ, Netsch C (2018) Thulium vapoenucleation of the prostate versus holmium laser enucleation of the prostate for the treatment of large volume prostates: preliminary 6-month safety and efficacy results of a prospective randomized trial. World J Urol. https://​doi.​org/​10.​1007/​s00345-018-2321-8
Metadata
Title
Thulium vapoenucleation of the prostate (ThuVEP) for prostates larger than 85 ml: long-term durability of the procedure
Authors
Benedikt Becker
Ann Kathrin Orywal
Andreas J. Gross
Christopher Netsch
Publication date
01-10-2019
Publisher
Springer London
Published in
Lasers in Medical Science / Issue 8/2019
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI
https://doi.org/10.1007/s10103-019-02760-1

Other articles of this Issue 8/2019

Lasers in Medical Science 8/2019 Go to the issue